{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:41:00Z","timestamp":1791484860305,"version":"4.3.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Adv Pharm Technol Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/2231-4040.197388","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T04:00:16Z","timestamp":1485316816000},"page":"29","source":"Crossref","is-referenced-by-count":16,"title":["Effectiveness and safety of topical tacrolimus in treatment of vitiligo"],"prefix":"10.4103","volume":"8","author":[{"given":"Hamta","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GhasemRahmatpour","family":"Rokni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Golpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AlimoradHeidari","family":"Gorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2231-4040.197388-1","first-page":"169","volume-title":"Tacrolimus 0,1% ointment in the treatment of vitiligo: A series of cases","author":"Tamler","year":"2011","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/2231-4040.197388-2","first-page":"1","volume-title":"Concise review of recent studies in vitiligo","author":"Allam","year":"2013","journal-title":"Qatar Med J"},{"key":"key-10.4103\/2231-4040.197388-3","first-page":"187","volume-title":"Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: A comprehensive literature review","author":"Sisti","year":"2016","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/2231-4040.197388-4","first-page":"921","volume-title":"Stress in patients with alopecia areata and vitiligo","author":"Manolache","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2231-4040.197388-5","first-page":"142","volume-title":"Quality of life and psychological morbidity in vitiligo patients: A study in a teaching hospital from North-East India","author":"Sangma","year":"2015","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2231-4040.197388-6","first-page":"41","volume-title":"Vitiligo and emotions","author":"Nogueira","year":"2009","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/2231-4040.197388-7","first-page":"58","volume-title":"Quality of life in patients with vitiligo","author":"Parsad","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"key-10.4103\/2231-4040.197388-8","unstructured":"Habif T. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. Edinburgh, UK, New York: Mosby Elsevier; 2013."},{"key":"key-10.4103\/2231-4040.197388-9","first-page":"638","volume-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: An open prospective study","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2231-4040.197388-10","first-page":"474","volume-title":"Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: Results of a placebo-controlled 12-month prospective study","author":"Hartmann","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2231-4040.197388-11","first-page":"495","volume-title":"Calcipotriene and corticosteroid combination therapy for vitiligo","author":"Travis","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/2231-4040.197388-12","first-page":"536","volume-title":"Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo","author":"Udompataikul","year":"2011","journal-title":"J Dermatol"},{"key":"key-10.4103\/2231-4040.197388-13","first-page":"217","volume-title":"New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris","author":"Mattox","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/2231-4040.197388-14","first-page":"220","volume-title":"Increased prevalence of chronic autoimmune (Hashimoto\u2032s) thyroiditis in children and adolescents with vitiligo","author":"Kakourou","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2231-4040.197388-15","first-page":"446","volume-title":"Quality of life and emotional state in vitiligo in an Estonian sample: Comparison with psoriasis and healthy controls","author":"Karelson","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2231-4040.197388-16","doi-asserted-by":"crossref","unstructured":"Vijayalakshmi P, Rao N, Priseela T. A comparative study of clobetasol propionat (0.05%) cream and tacrolimus (0.1%) ointment in the management of vitiligo. JEBMH 2015;2:724-8.","DOI":"10.18410\/jebmh\/2015\/101"},{"key":"key-10.4103\/2231-4040.197388-17","doi-asserted-by":"crossref","unstructured":"Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003;139:581-5.","DOI":"10.1001\/archderm.139.5.581"},{"key":"key-10.4103\/2231-4040.197388-18","first-page":"236","volume-title":"A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter","author":"Park","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2231-4040.197388-19","first-page":"13","volume-title":"Frequency of depression in patients suffering from vitiligo","author":"Esfandiaripour","year":"2003","journal-title":"Iran J Dermatol"}],"container-title":["Journal of Advanced Pharmaceutical Technology & Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:26:15Z","timestamp":1786713975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2231-4040.197388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["197388"],"URL":"https:\/\/doi.org\/10.4103\/2231-4040.197388","relation":{},"ISSN":["2231-4040"],"issn-type":[{"value":"2231-4040","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}